Mark Wilterding - 28 Feb 2026 Form 4 Insider Report for RxSight, Inc. (RXST)

Reporting relationship: Chief Financial Officer
Issuer ticker: RXST
Reported as of: 28 Feb 2026
Net transaction value: -$61,397
SEC form: 4
Accepted by SEC: 03 Mar 2026, 20:24:10 UTC
Prior SEC filing: 30 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Jim Schindler, as Attorney-in-Fact

Key filing fact

Mark Wilterding filed Form 4 for RxSight, Inc. (RXST) on 03 Mar 2026.

Key facts

This page summarizes Mark Wilterding's Form 4 filing for RxSight, Inc. (RXST).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 20:24.

Change

Previous filing in this sequence was filed on 30 Jan 2026.
Current net transaction value: -$61,397.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002107187 Primary reporting owner

Wilterding Mark

Relationship: Chief Financial Officer
Address: 100 COLUMBIA, ALISO VIEJO
Signature: /s/ Jim Schindler, as Attorney-in-Fact
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXST transaction

Common Stock

Options Exercise

Transaction value
Shares: +20,441
Change %
Price
Shares after: 20,441
Date: 28 Feb 2026
Ownership: Direct
Footnotes: F1

RXST transaction

Common Stock

Tax liability

Transaction value: $61,397
Shares: -8,068
Change %: -39%
Price: $7.61
Shares after: 12,373
Date: 28 Feb 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXST transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -20,441
Change %: -12%
Price: $0.000000
Shares after: 143,087
Date: 28 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,441
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award vested on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.

SEC remarks

Exhibit 24 - Power of Attorney